ESR1 Mutated Metastatic Breast Cancer Diagnostics Market By Test Type (NGS Based and PCR Based), By Sample Type (Plasma and Tissue), By End-user (Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, and Cancer Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Size is expected to be worth around US$ 91.8 million by 2034 from US$ 63.2 million in 2024, growing at a ...